Barriers and Facilitators for Guidelines with Depression and Anxiety in Parkinson’s Disease or Dementia

2018 ◽  
Vol 37 (2) ◽  
pp. 185-199 ◽  
Author(s):  
Zahra Goodarzi ◽  
Heather M. Hanson ◽  
Nathalie Jette ◽  
Scott Patten ◽  
Tamara Pringsheim ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Behaviour Change ◽  
Barriers And Facilitators ◽  
Depression And Anxiety ◽  
Maladie De Parkinson ◽  
Behaviour Change Wheel ◽  
Groupes De Discussion ◽  
Pratique Clinique

RÉSUMÉNotre principal objectif était de comprendre les barrières et les facilitateurs associés à l’application de guides de pratique clinique (GPC) de haute qualité pour la dépression et l’anxiété chez les patients atteint de démence ou de la maladie de Parkinson (MP). Des groupes de discussion et des entrevues ont été réalisés avec des participants atteints de démence ou de la MP, leurs soignants et les médecins impliqués dans les soins de ces patients à Calgary (Alberta). Le cadre conceptuel des domaines théoriques et le Behaviour Change Wheel ont été utilisés pour guider la collecte des données et l’analyse du cadre conceptuel. Au total, 33 médecins, 7 patients et leurs aidants ont participé à l’étude. Les barrières et les facilitateurs pour l’application des recommandations des GPC liées au diagnostic, à la gestion et à l’utilisation des lignes directrices ont été rapportés. L’insuffisance des données concernant les troubles anxieux et dépressifs dans la démence et la MP constituaient un thème dominant dans les résultats. Ce constat était particulièrement évident en matière de troubles anxieux. Les patients ont aussi mentionné des difficultés à communiquer leurs symptômes et à accéder aux services. Bien que des guides de pratiques soient disponibles, les médecins éprouvent quelques difficultés dans l’application de certaines recommandations, ces difficultés étant surtout dues au manque de données probantes disponibles.

scholarly journals BARRIERS AND FACILITATORS TO GUIDELINE USE IN DEPRESSION AND ANXIETY IN PARKINSON’S DISEASE OR DEMENTIA

2017 ◽  
Vol 1 (suppl_1) ◽  
pp. 487-487 ◽  
Author(s):  
Z. Goodarzi ◽  
H. Hanson ◽  
N. Jette ◽  
S. Patten ◽  
T. Pringsheim ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Barriers And Facilitators ◽  
Depression And Anxiety

scholarly journals Impact of Depression and Anxiety on Dimensions of Health-Related Quality of Life in Subjects with Parkinson’s Disease Enrolled in an Association of Patients

2021 ◽  
Vol 11 (6) ◽  
pp. 771
Author(s):  
Fany Chuquilín-Arista ◽  
Tania Álvarez-Avellón ◽  
Manuel Menéndez-González
Keyword(s):  
Quality Of Life ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Psychiatric Symptoms ◽  
Well Being ◽  
Depression And Anxiety ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related

Parkinson’s disease (PD) is a complex disorder characterized by a wide spectrum of symptoms. Depression and anxiety are common manifestations in PD and may be determinants of health-related quality of life (HRQoL). The objective of this study is to determine the association of depression and anxiety with the dimensions of HRQoL in subjects with PD enrolled in an association of patients. Ninety-five community-based patients with PD diagnosis at different disease stages were studied. HRQoL was assessed using the Parkinson’s Disease Questionnaire (PDQ-39); depression and anxiety were assessed using the Beck Depression Inventory (BDI-II) and the State-Trait Anxiety Inventory (STAI), respectively. Our results showed that depression and anxiety were negatively associated with HRQoL measured by PDSI. Higher motor dysfunction measured by Hoehn and Yahr (H&Y) staging was also associated with worse HRQoL. Depression was the most influential variable in the model. All PDQ-39 dimensions except social support and bodily discomfort were associated with depression. Anxiety was associated with the emotional well-being and bodily discomfort dimensions. These results suggest that physicians should pay attention to the presence of psychiatric symptoms and treat them appropriately.

Barriers and Facilitators for Participation in People with Parkinson’s Disease

2015 ◽  
Vol 5 (4) ◽  
pp. 983-992 ◽  
Author(s):  
Maria H. Nilsson ◽  
Susanne Iwarsson ◽  
Björg Thordardottir ◽  
Maria Haak
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Barriers And Facilitators

scholarly journals Occurrence of depression and anxiety prior to Parkinson’s disease

2010 ◽  
Vol 16 (9) ◽  
pp. 576-581 ◽  
Author(s):  
E.L. Jacob ◽  
N.M. Gatto ◽  
A. Thompson ◽  
Y. Bordelon ◽  
B. Ritz
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Depression And Anxiety

scholarly journals Depression and anxiety related subtypes in Parkinson's disease

2011 ◽  
Vol 82 (7) ◽  
pp. 803-809 ◽  
Author(s):  
R. G. Brown ◽  
S. Landau ◽  
J. V. Hindle ◽  
J. Playfer ◽  
M. Samuel ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Depression And Anxiety

scholarly journals Distress in Parkinson's disease: Contributions of disease factors and metacognitive style

2005 ◽  
Vol 187 (2) ◽  
pp. 182-183 ◽  
Author(s):  
Rory Allott ◽  
Adrian Wells ◽  
Anthony P. Morrison ◽  
Richard Walker
Keyword(s):  
Risk Factors ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Psychological Factor ◽  
Psychological Interventions ◽  
Depression And Anxiety ◽  
Future Directions ◽  
Related Risk

SummaryResearch has suggested that the high levels of depression and anxiety observed in Parkinson's disease are a primary consequence of its pathophysiology. This study aimed to test the hypothesis that a psychological factor, metacognitive style, is significantly associated with distress, independent of previously identified disease-related risk factors. Distress, metacognitive style and disease factors were assessed in 44 people with a diagnosis of Parkinson's disease. People with a specific metacognitive style had an increased vulnerability to distress over and above previously identified disease factors; this suggests future directions for the development of psychological interventions.

William J. Weiner, Lisa M. Shulman, and Anthony E. Lang Parkinson's disease: A complete guide for patients and families. Baltimore, MD: Johns Hopkins University Press, 2001.

2002 ◽  
Vol 21 (2) ◽  
pp. 317-319
Author(s):  
Leslie D. Frazier
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Maladie De Parkinson ◽  
Parkinsons Disease ◽  
Johns Hopkins University

RÉSUMÉLa maladie de Parkinson est une affection chronique neurologique dégénérative qui affecte environ un million de personnes en Amérique du Nord. Or, tous les patients atteints de la maladie doivent être bien informés; ils ont surtout besoin d'en comprendre les symptômes et la progression pour être en mesure de l'affronter efficacement. Parkinsons disease: A complete guide for patients and families par Weiner, Shulman et Lang (2001) constitue une ressource précieuse pour les patients, leurs familles et les soignants qui travaillent auprès de cette population. Le livre fournit une bonne quantité d'information biomédicale sur la maladie. Les données sont communiquées selon un modèle élémentaire qui éduque le lecteur mais qui lui permet aussi de s'assumer et qui lui aide éventuellement à faire face à sa maladie. Le livre présente toutefois certaines faiblesses qu'il faut signaler, dont entre autres, le fait que l'approche biomédicale écarte les questions psychosociales reliées à la maladie. Une autre faiblesse porte sur l'absence de mention des efforts scientifiques récents dans d'autres secteurs que la médecine clinique. Enfin, il porte peu d'attention aux interventions thérapeutiques qui ne sont pas du domaine médical ou pharmacologique. Les auteurs renvoient à d'autres sources les lecteurs qui souhaitent se renseigner sur ces éléments.

scholarly journals Anxiety and anxious-depression in Parkinson's disease over a 4-year period: a latent transition analysis

2015 ◽  
Vol 46 (3) ◽  
pp. 657-667 ◽  
Author(s):  
S. Landau ◽  
V. Harris ◽  
D. J. Burn ◽  
J. V. Hindle ◽  
C. S. Hurt ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Age Of Onset ◽  
Latent Transition Analysis ◽  
Depression And Anxiety ◽  
Transition Analysis ◽  
Anxious Depression ◽  
Younger Age ◽  
Latent Transition ◽  
Severe Anxiety

BackgroundDepression and anxiety in Parkinson's disease are common and frequently co-morbid, with significant impact on health outcome. Nevertheless, management is complex and often suboptimal. The existence of clinical subtypes would support stratified approaches in both research and treatment.MethodFive hundred and thirteen patients with Parkinson's disease were assessed annually for up to 4 years. Latent transition analysis (LTA) was used to identify classes that may conform to clinically meaningful subgroups, transitions between those classes over time, and baseline clinical and demographic features that predict common trajectories.ResultsIn total, 64.1% of the sample remained in the study at year 4. LTA identified four classes, a ‘Psychologically healthy’ class (approximately 50%), and three classes associated with psychological distress: one with moderate anxiety alone (approximately 20%), and two with moderate levels of depression plus moderate or severe anxiety. Class membership tended to be stable across years, with only about 15% of individuals transitioning between the healthy class and one of the distress classes. Stable distress was predicted by higher baseline depression and psychiatric history and younger age of onset of Parkinson's disease. Those with younger age of onset were also more likely to become distressed over the course of the study.ConclusionsPsychopathology was characterized by relatively stable anxiety or anxious-depression over the 4-year period. Anxiety, with or without depression, appears to be the prominent psychopathological phenotype in Parkinson's disease suggesting a pressing need to understanding its mechanisms and improve management.

Sign in / Sign up

Export Citation Format

Share Document